MassDevice.com +5 | The top 5 medtech stories for June 21, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. CBO scores Senate’s FDA user fees bill The Congressional Budget Office last week scored a U.S. Senate bill to re-up the user fee agreement between the medical device and pharmaceutical industries, saying it would add $740 million to the budget and a negligible amount to the deficit over 2017 to 2022. The “FDA Reauthorization Act of 2017” would see medical device companies put up a collective $1 billion in user fees, which pharma firms putting up another $8 billion for drug reviews, the budget office estimated. That money, the fees companies pay to have the federal safety watchdog review their products, would offset most of the increase in net discretionary spending, according to the CBO. The bill would raise direct spending by $13 million and lower revenues by $2 million from 2017 to 2022 but raise the total deficit by a paltry $15 million from 2017 to 2027, the CBO estimated. Read more 4. Staar Surgical settles shareholder class action suit for $7m Staar Surgical has reached a $7 million settlement deal to end an investor suit claiming that the company concealed pro...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news